Literature DB >> 26011473

Ketogenic diet exhibits anti-inflammatory properties.

Nina Dupuis1,2, Niccolo Curatolo1, Jean-François Benoist1,3, Stéphane Auvin1,2,4.   

Abstract

The ketogenic diet (KD) is an established treatment for refractory epilepsy, including some inflammation-induced epileptic encephalopathies. In a lipopolysaccharide (LPS)-induced fever model in rats, we found that animals given the KD for 14 days showed less fever and lower proinflammatory cytokine levels than control animals. However, KD rats exhibited a decrease in circulating levels of arachidonic acid and long-chain n-3 polyunsaturated fatty acids (PUFAs), suggesting that the anti-inflammatory effect of KD was probably not due to an increase in anti-inflammatory n-3 PUFA derivatives. These properties might be of interest in some conditions such as fever-induced refractory epileptic encephalopathy in school-aged children. Wiley Periodicals, Inc.
© 2015 International League Against Epilepsy.

Entities:  

Keywords:  Epilepsy; FIRES; IL-1β; Ketogenic diet; Polyunsaturated fatty acids

Mesh:

Substances:

Year:  2015        PMID: 26011473     DOI: 10.1111/epi.13038

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  48 in total

Review 1.  New insights into the mechanisms of the ketogenic diet.

Authors:  Detlev Boison
Journal:  Curr Opin Neurol       Date:  2017-04       Impact factor: 5.710

2.  Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus.

Authors:  Mackenzie C Cervenka; Sara Hocker; Matthew Koenig; Barak Bar; Bobbie Henry-Barron; Eric H Kossoff; Adam L Hartman; John C Probasco; David R Benavides; Arun Venkatesan; Eliza C Hagen; Denise Dittrich; Tracy Stern; Batya Radzik; Marie Depew; Filissa M Caserta; Paul Nyquist; Peter W Kaplan; Romergryko G Geocadin
Journal:  Neurology       Date:  2017-02-08       Impact factor: 9.910

3.  A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder.

Authors:  Ryan W Y Lee; Michael J Corley; Alina Pang; Gaye Arakaki; Lisa Abbott; Michael Nishimoto; Rob Miyamoto; Erica Lee; Susan Yamamoto; Alika K Maunakea; Annette Lum-Jones; Miki Wong
Journal:  Physiol Behav       Date:  2018-02-05

Review 4.  The changing face of dietary therapy for epilepsy.

Authors:  Ludovica Pasca; Valentina De Giorgis; Joyce Ann Macasaet; Claudia Trentani; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Eur J Pediatr       Date:  2016-09-01       Impact factor: 3.183

5.  A bioenergetics systems evaluation of ketogenic diet liver effects.

Authors:  Lewis J Hutfles; Heather M Wilkins; Scott J Koppel; Ian W Weidling; J Eva Selfridge; Eephie Tan; John P Thyfault; Chad Slawson; Aron W Fenton; Hao Zhu; Russell H Swerdlow
Journal:  Appl Physiol Nutr Metab       Date:  2017-05-17       Impact factor: 2.665

Review 6.  Ketogenic diet, neuroprotection, and antiepileptogenesis.

Authors:  Madhuvika Murugan; Detlev Boison
Journal:  Epilepsy Res       Date:  2020-08-19       Impact factor: 3.045

7.  Clinical studies and anti-inflammatory mechanisms of treatments.

Authors:  Jacqueline A French; Matthias Koepp; Yvonne Naegelin; Federico Vigevano; Stéphane Auvin; Jong M Rho; Evan Rosenberg; Orrin Devinsky; Peder S Olofsson; Marc A Dichter
Journal:  Epilepsia       Date:  2017-07       Impact factor: 5.864

Review 8.  Towards Tailored Gut Microbiome-Based and Dietary Interventions for Promoting the Development and Maintenance of a Healthy Brain.

Authors:  Ana Larroya; Jorge Pantoja; Pilar Codoñer-Franch; María Carmen Cenit
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

9.  Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy.

Authors:  Melissa L Barker-Haliski; Wolfgang Löscher; H Steve White; Aristea S Galanopoulou
Journal:  Epilepsia       Date:  2017-07       Impact factor: 6.740

Review 10.  Metabolic Control of Smoldering Neuroinflammation.

Authors:  Luca Peruzzotti-Jametti; Cory M Willis; Regan Hamel; Grzegorz Krzak; Stefano Pluchino
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.